PODD analyst estimates
Insulet (PODD) analyst ratings, the average price target and its range, and every firm's latest call.
PODD analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Oct 12, 2026 | Jefferies | Insulet Corporation (PODD) PT Lowered to $190 at Jefferies | $190.00 |
| Oct 6, 2026 | Barclays | Insulet initiated with an Equal Weight at Barclays | $150.00 |
| Aug 6, 2026 | Canaccord Genuity | Insulet Corporation (PODD) PT Lowered to $179 at Canaccord | $179.00 |
| Aug 6, 2026 | Raymond James | Insulet Corporation (PODD) PT Lowered to $180 at Raymond James | $180.00 |
| Aug 6, 2026 | RBC Capital | Insulet price target lowered to $160 from $245 at RBC Capital | $160.00 |
| Aug 6, 2026 | Leerink Partners | Insulet downgraded to Market Perform from Outperform at Leerink | $145.00 |
| Aug 6, 2026 | Bernstein | Insulet price target lowered to $175 from $200 at Bernstein | $175.00 |
| Aug 6, 2026 | Robert W. Baird | Insulet price target lowered to $175 from $248 at Baird | $175.00 |
| Aug 5, 2026 | Truist Financial | Insulet downgraded to Hold from Buy at Truist | $153.00 |
| Aug 5, 2026 | Wells Fargo | Insulet downgraded to Equal Weight from Overweight at Wells Fargo | $144.00 |
| Jul 28, 2026 | UBS | Insulet assumed with Neutral from Buy at UBS | $174.00 |
| Jul 13, 2026 | RBC Capital | Insulet price target lowered to $245 from $280 at RBC Capital | $245.00 |
| Jul 13, 2026 | Truist Financial | Insulet price target lowered to $210 from $219 at Truist | $210.00 |
| Jul 10, 2026 | Stifel Nicolaus | Insulet Corporation (PODD) PT Lowered to $225 at Stifel as Guidance Raise ExpectedMember Login | $225.00 |
| Jul 6, 2026 | Evercore ISI | Insulet price target lowered to $180 from $200 at Evercore ISI | $180.00 |
- 21 firms rate PODD: 11 buy, 10 hold, 0 sell.
- The average price target is $171.54 from 13 analysts, from $144.00 to $225.00.
Updated 2026-11-02 23:11 UTC